Skip to main content
. 2017 Mar 21;2017(3):CD004454. doi: 10.1002/14651858.CD004454.pub3
Methods Type of study: RCT Method of treatment allocation: method of randomisation not stated. Coded drug boxes were provided. Randomisation code was kept on file at the Pharmacy Department of Toronto General Hospital. Stratification: yes, by gestational age into 2 subgroups; 24‐32 weeks and 33‐34 weeks Placebo: yes, vehicle of steroid preparation consisting of 0.2 mg benzalkonium chloride and 0.1 mg disodium edentate per mL Sample size calculation: no Intention‐to‐treat analyses: yes Losses to follow‐up: no Funding: The Hospital for Sick Children Foundation, Canada; Schering Corporation, Canada; Ontario Ministry of Health Provincial Research Grant PR 279, Canada
Participants Location: 6 teaching hospitals in Toronto, Canada Timeframe: January 1975‐June 1978 Eligibility criteria: women with PROM, spontaneous preterm labour or planned preterm delivery Gestational age range: 24 and 34 weeks. Exclusion criteria: women with pre‐eclampsia or in whom steroids were contraindicated on medical grounds. Total recruited: 137 women and 144 infants; 75 women and 81 infants in the treatment arm and 62 women and 63 infants in the control arm
Interventions 4 doses of 3 mg betamethasone acetate and 3 mg betamethasone sodium phosphate IM 12 h apart Control group received 4 doses of identical placebo
Outcomes Fetal/neonatal outcomes were reported (fetal death, neonatal death, RDS, IVH, birthweight, days of mechanical ventilation)
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Method of randomisation not stated
Allocation concealment (selection bias) Low risk Coded drug boxes were provided. Randomisation code was kept on file at the Pharmacy Department of Toronto General Hospital.
Blinding of participants and personnel (performance bias) All outcomes Low risk It is likely that participants were blinded as both placebo and corticosteroid solutions were identical. Blinding of study personnel was not described other than to state "double blind".
Blinding of outcome assessment (detection bias) All outcomes Low risk Blinding of outcome assessors was not described, but is likely as the authors state "The key to the code was not broken until the whole study was completed".
Incomplete outcome data (attrition bias) All outcomes Low risk No losses to follow‐up
Selective reporting (reporting bias) Low risk Study protocol not available, but appears to report on all pre‐specified outcomes
Other bias Unclear risk Insufficient information to asses if other sources of bias exist